Primary Site >> Stomach Cancer
Gene >> ALK
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Stromal tumor of the stomach in a 14 year old girl]. PMID: 14679701 |
Ref: ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement. PMID: 15492998 |
Ref: From morphological to molecular diagnosis of soft tissue tumors. PMID: 17163160 |
Ref: Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway. PMID: 18174246 |
Ref: Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. PMID: 20526349 Ref: EML4-ALK fusion transcripts in immunohistochemically ALK-positive non-small cell lung carcinomas. PMID: 22993539 |
Ref: [Recent results of research on cancer of the colon, gastric cancer, sarcoma and bronchial carcinoma]. PMID: 21271476 |
Ref: Identification of ROS1 rearrangement in gastric adenocarcinoma. PMID: 23400546 Ref: Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part I: Targeting receptor tyrosine kinase gene amplification. PMID: 23819947 Ref: Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part II: Targeting gene mutations and gene amplifications and the angiogenesis pathway. PMID: 23911227 Ref: The utility of immunohistochemistry for providing genetic information on tumors. PMID: 24065374 Ref: Aminopyridyl/Pyrazinyl Spiro[indoline-3,4'-piperidine]-2-ones As Highly Selective and Efficacious c-Met/ALK Inhibitors. PMID: 24900750 |
Ref: The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer. PMID: 25707491 Ref: Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies. PMID: 25882375 Ref: Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening. PMID: 26172300 Ref: Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population. PMID: 26678488 |
Ref: MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer. PMID: 26404902 Ref: Primary gastric anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma. PMID: 27695344 Ref: Therapeutics Targeting FGF Signaling Network in Human Diseases. PMID: 27992319 |
Ref: Plexiform angiomyxoid myofibroblastic tumor of the stomach: A case report. PMID: 27561459 Ref: [A Case of Synchronous Double Cancer of the Lung and Stomach That Responded to Cisplatin and S-1 Combination Chemotherapy]. PMID: 28174383 Ref: Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma. PMID: 28176910 Ref: Nivolumab Therapy for Synchronous ALK-Positive Lung Cancer and Gastric Cancer. PMID: 28559820 Ref: Diagnostic utility of automated SureFISH (Dako Omnis) in the diagnosis of musculoskeletal translocation-related sarcomas. PMID: 28735509 Ref: ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis. PMID: 28923119 Ref: In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs. PMID: 29125233 |
Ref: [Clinicopathologic features of gastric plexiform fibromyxoma]. PMID: 29690664 Ref: Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma. PMID: 30038504 Ref: Double amplifications of CDK4 and MDM2 in a gastric inflammatory myofibroblastic tumor mimicking cancer with local invasion of the spleen and diaphragm. PMID: 30252584 |